According to the neurotrophin hypothesis for AD, therapies aimed at restoring the homeostatic balance between ligands and receptors of the neurotrophin pathway appear to have a truly disease‐modifying efficacy (Cattaneo and Calissano 2012). Here, BDNF is linked to Alzheimer disease.